Ge Healthcare Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?
GE HEALTHCARE has forty-nine approved drugs.
There are six US patents protecting GE HEALTHCARE drugs.
There are eighty patent family members on GE HEALTHCARE drugs in twenty-six countries and one hundred and thirty-two supplementary protection certificates in eighteen countries.
Summary for Ge Healthcare
| International Patents: | 80 |
| US Patents: | 6 |
| Tradenames: | 57 |
| Ingredients: | 38 |
| NDAs: | 49 |
| Drug Master File Entries: | 5 |
Drugs and US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | TECHNETIUM TC 99M MPI MDP | technetium tc-99m medronate kit | INJECTABLE;INJECTION | 018141-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Ge Healthcare | AMERSCAN MDP KIT | technetium tc-99m medronate kit | INJECTABLE;INJECTION | 018335-001 | Aug 5, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Ge Healthcare | VIZAMYL | flutemetamol f-18 | INJECTABLE;INTRAVENOUS | 203137-002 | Oct 25, 2013 | RX | Yes | Yes | 8,691,185 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ge Healthcare | VIZAMYL | flutemetamol f-18 | INJECTABLE;INTRAVENOUS | 203137-002 | Oct 25, 2013 | 7,351,401 | ⤷ Try a Trial |
| Ge Healthcare | VIZAMYL | flutemetamol f-18 | INJECTABLE;INTRAVENOUS | 203137-001 | Oct 25, 2013 | 8,691,185 | ⤷ Try a Trial |
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | RE36418 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Ge Healthcare Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hungary | 1500560 | ⤷ Try a Trial |
| Portugal | 2182988 | ⤷ Try a Trial |
| Hong Kong | 1146725 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ge Healthcare Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1611115 | 1590010-3 | Sweden | ⤷ Try a Trial | PRODUCT NAME: FLUTEMETAMOL (18F); REG. NO/DATE: EU/1/14/941 20140826 |
| 0216511 | 94C0015 | Belgium | ⤷ Try a Trial | PRODUCT NAME: GADODIAMIDE; NAT. REGISTRATION NO/DATE: NL 19253 19940425; FIRST REGISTRATION: GB - 0637/0015 19920925 |
| 2182988 | 2015006 | Norway | ⤷ Try a Trial | PRODUCT NAME: VIZAMYL; REG. NO/DATE: EU/1/14/941 20140822 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
